Your privacy is very important for us. When you visit our website, please agree to use all cookies. For more information about how we use cookies, please visit our Privacy Policy.

    • logo1-902.png
      2022-10-26

      34th EORTC-NCI-AACR Symposium

      Preclinical activity for TPX-4589 (LM-302), an antibody-drug conjugate targeting tight junction protein CLDN18.2 in solid tumors, Wentao Huang, Yifan Li, Zhifang Liu, Laura Rodon, Stephanie Correia, Yuan Li, Runsheng Li